Affiliation:
1. School of Surgery, University of Western Australia Medical School, The University of Western Australia (M509), Perth, Australia
Abstract
This commentary addresses the article “Toward a Sociology of Plasma Products” by Holloway and Grundy in this issue of the International Journal of Social Determinants of Health and Health Services. The program of research proposed by the authors positioning the medico-industrial field of plasma products within a sociological context is supported, this being an endeavor which has not been attempted previously. I seek to augment Holloway and Grundy's proposed approach through some additional insights which are the result of over forty years of personal commitment in the field. Holloway and Grundy's proposed areas of engagement involving the products, the recipients, the donors and the governance of the systems binding these together is widened through an examination of additional technological factors that have shaped the field. These factors include the influence of the medical industry, the role of patient groups, the continuing controversy on the sourcing of plasma raw material, and the roles of different governance models. Converging these factors with Holloway and Grundy's proposed program should enhance its capacity to develop a framework for understanding the dynamics within this complex and unique sector. The concepts developed in both articles will assist stakeholders to develop a societal framework for the provision of these essential medicines.
Reference22 articles.
1. The legacy of haemophilia: Memories and reflections from three survivors
2. Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012
3. Becker Z. Costing $3.5M, first hemophilia B gene therapy wins FDA approval. Published November 23, 2022. Accessed April 18, 2024. https://www.fiercepharma.com/pharma/csl-and-uniqures-hemophilia-b-gene-therapy-scores-approval-35-million-price-tag.
4. European Commission. Commission welcomes European Parliament’s adoption of the European Health Data Space and regulation on substances of human origin. European Commission - European Commission. Published April 24, 2024. Accessed April 26, 2024. https://ec.europa.eu/commission/presscorner/detail/en/IP_24_2250.
5. A Brief History of Evidence-Based Medicine (EBM) and the Contributions of Dr David Sackett